Sun Pharma and SPARC Announce US FDA Approval of XELPROS™ to Treat Open-angle Glaucoma or Ocular Hypertension
MUMBAI, India & PRINCETON, N.J.--(BUSINESS WIRE)--#BAK--Sun Pharma’s XELPROS™ (latanoprost ophthalmic emulsion) 0.005% approved by the U.S. FDA